Letter to the Editor
Paraneoplastic sensory neuropathy and Purkinje cell antibodies
Brian Mc Namara MD,
Brian Mc Namara MD
Department of Clinical Neurophysiology, Box 124, Addenbrookes Hospital, Cambridge, England
Search for more papers by this author Simon J. Boniface MD,
Simon J. Boniface MD
Department of Clinical Neurophysiology, Box 124, Addenbrookes Hospital, Cambridge, England
Search for more papers by this author Julian Ray MB,
Julian Ray MB
Department of Clinical Neurophysiology, Box 124, Addenbrookes Hospital, Cambridge, England
Search for more papers by this author Neil J. Scolding PhD,
Neil J. Scolding PhD
Department of Neurology, Addenbrookes Hospital, Cambridge, England
Search for more papers by this author Neil Robertson MD,
Neil Robertson MD
Department of Neurology, Addenbrookes Hospital, Cambridge, England
Search for more papers by this author
Brian Mc Namara MD,
Brian Mc Namara MD
Department of Clinical Neurophysiology, Box 124, Addenbrookes Hospital, Cambridge, England
Search for more papers by this author Simon J. Boniface MD,
Simon J. Boniface MD
Department of Clinical Neurophysiology, Box 124, Addenbrookes Hospital, Cambridge, England
Search for more papers by this author Julian Ray MB,
Julian Ray MB
Department of Clinical Neurophysiology, Box 124, Addenbrookes Hospital, Cambridge, England
Search for more papers by this author Neil J. Scolding PhD,
Neil J. Scolding PhD
Department of Neurology, Addenbrookes Hospital, Cambridge, England
Search for more papers by this author Neil Robertson MD,
Neil Robertson MD
Department of Neurology, Addenbrookes Hospital, Cambridge, England
Search for more papers by this author
First published: 15 September 1999
No abstract is available for this article.
REFERENCES
- 1Dropcho EJ. Autoimmune central nervous system paraneoplastic disorders: mechanisms, diagnosis, and therapeutic options. Ann Neurol 1995 ; 37 Suppl 1: S102–S113.
Medline
- 2Fathallah-Shaykh H, Wolf S, Wong E, Posner JB, Furneaux HM. Cloning of a leucine-zipper protein recognized by the sera of patients with antibody-associated paraneoplastic cerebellar degeneration. Proc Natl Acad Sci USA 1991; 15;88: 3451–3454.
- 3Furneaux HM, Rosenblum, MK, Dalmau, J, Wong, E, Woodruff, P, Graus, F, Posner, JB. Selective expression of purkinje cell antigens in tumor tissue. N Engl J Med 1990; 322: 1844–1851.
Medline
- 4Hawley RJ, Cohen MH, Saini N, Armsbrustmacher VW. The carcinomatosis neuromyopathy of oat cell lung cancer. Ann Neurol 1980; 7: 65–72.
Medline
- 5Ma DM, Liveson JA. Nerve conduction handbook. Philadelphia: FA Davis Company; 1983. 384 p.
- 6Nemni R, Camerlingo M, Fazio R, Castro L, Quattrini A, Mamoli D, Lorenzetti I, Canal N, Mamoli A. Serum antibodies to Purkinje cells and dorsal root ganglia neurons in sensory neuronopathy without malignancy. Ann Neurol 1993; 34: 848–854.
Medline
- 7Peterson K, Rosenblum MK, Kotanides H, Posner JB. Paraneoplastic cerebellar degeneration: a clinical analysis of 55 anti-Yo antibody positive patients. Neurology 1992: 42; 1931–1937.
Medline
- 8Scolding N, Paraneoplastic disorders of the central nervous system. In: N Scolding, editor. Immunological and inflammatory diseases of the central nervous system. Oxford: Butterworth-Heinemann; 1999. p 118–138.
- 9Shamsuddin K, Sripathi N, Ahmad BK Lennon VA. Paraneoplastic motor neuron disease with type 1 purkinje cell antibodies. Muscle Nerve 21: 943–945.
- 10Stugben JP. The neuromuscular disorders in systemic malignancy. Curr Opin Neurol 1996; 10: 371–375.
